跳至主要内容
临床试验/DRKS00025879
DRKS00025879已完成未知

Investigate the effects of a spermidine supplementation on immune system and inflammatory parameters in old and young adults - ImmuneAge-Study

Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DIfE)0 个研究点目标入组 40 人开始时间: 2022年4月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
25 Years 至 90 Years(—)
性别
All

入选标准

  • Young adults: age: 25-40 years; BMI: 20-30 kg/m²; no chronic medication except for oral contraceptives;
  • Old adults: age: 70-90 years; BMI: 20-30 kg/m²;
  • No limitations in ‘’activities of daily living’’;
  • Subjects must be able to consent as defined by law.

排除标准

  • Pregnancy/breastfeeding;
  • Existing or past immune diseases such as leukemia, lymphoma, malignant neoplasms affecting bone marrow and lymphatic system, HIV or AIDS;
  • Self-reported severe or active medical conditions such as arteriosclerosis, advanced cardiac or respiratory disease, such as chronic obstructive pulmonary disease (COPD; GOLD-Stadium =3 (Global Initiative for Chronic Obstructive Lung Disease”-classification)) or heart failure (NYHA =3 (New York Heart Association));
  • Self-reported neurological or mental impairment;
  • Self-reported severe liver, kidney, or metabolic disease, such as liver cirrhosis (Child Pugh Score =2) or kidney disease (Stadium =3);
  • Drug/medication/alcohol dependence;
  • Existing polyamine supplementation;
  • Known intolerances or allergies to wheat germ, gluten, or histamine.

研究者

相似试验